market in the year 2012. However, Canada
is expected to witness high growth due to growing prevalence of diabetes and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis, increase in approval of injectable formulation and device, favorable reimbursement and rise in injectable cosmetic treatments.
This research report categorizes and analyzes the North American injectable drug delivery technologies market under two broad segments - devices and formulations. Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Furthermore, due to wide range of applications of injectable drug delivery technologies in varied therapeutic areas, the market is segmented into five categories, namely; auto immune diseases, hormonal imbalances, oncology, orphan/rare diseases (Hemophilia, Ribose-5-phosphate isomerase deficiency (RPI deficiency), Cystic Fibrosis, Wilson's Disease) and others (pain management, allergies, hepatitis C, and aesthetic treatment).
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Injectable Drug Delivery Devices Technologies Market
5 Injectable Drug Delivery Formulation Technologies Market
6 Injectable Drug Delivery Technologies Market,By Therapeutic Applications
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles
- Antares Pharma, Inc.
- Baxter International, Inc.
- Becton, Dickinson And Company
- Eli Lilly And Company
- Hospira, Inc.
- Novo Nordisk A/S
- Unilife Corporation
- West Pharmaceutical Services, Inc.
- Zogenix, Inc.
For more information visit http://www.researchandmarket
Page: 1 2 3 Related biology technology :1
. BioSpace Spotlights Northwests Life Science Community2
. Northwest Bio Implements Major Balance Sheet Clean-Up3
. Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting4
. StemCyte Adds World Class Talent to its North America and Global Operations5
. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions6
. Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina7
. OncoSec to Present at 10th Annual BioPartnering North America8
. Northwest Bio and Fraunhofer IZI Announce Milestones Reached9
. Instrumentation Laboratory Moves To Direct Distribution Of Hemostasis Product Line In North America10
. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”11
. Glythera Relocates to North East as Part of £2M Funding Round